Refine
Year of publication
Document Type
- Article (32)
- Preprint (5)
- Review (2)
- Report (1)
- Working Paper (1)
Has Fulltext
- yes (41)
Is part of the Bibliography
- no (41)
Keywords
- Acuris (2)
- Decorin (2)
- Gene expression (2)
- IR-A (2)
- Pre-analytics (2)
- Proliferation (2)
- Signaling (2)
- ACURATE neo (1)
- ALL (1)
- AML (1)
- Amino acid analysis (1)
- Angiomyolipoma (1)
- Anlegerschutz (1)
- Anticonvulsant (1)
- BRCA1 (1)
- BRCA2 (1)
- Bacterial leakage (1)
- Bankberatung (1)
- Bike-Sharing (1)
- Blood sample handling (1)
- CAD/ CAM crown (1)
- CAD/CAM crown (1)
- CAKUT (1)
- Car-Sharing (1)
- Care centers (1)
- Cement gap (1)
- Computer-aided drug design (1)
- Congenital anomalies (1)
- Conometric connection (1)
- Consensus (1)
- Costs (1)
- DNA sequence analysis (1)
- Diagnostic differentiation (1)
- Elektromobilität (1)
- Embryos (1)
- Endocannabinoids (1)
- Endothelium (1)
- Epilepsy (1)
- Finanzbildung (1)
- Flottenkonzepte (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Genetics (1)
- Gesundheitspersonal (1)
- Gesundheitsversorgungseinrichtungen (1)
- Glioblastoma (1)
- Health facilities (1)
- Health personnel (1)
- Hereditary breast cancer (1)
- Hereditary ovarian cancer (1)
- Isoproterenol (1)
- K3EDTA plasma sampling (1)
- Ladeinfrastruktur (1)
- Lipidomics (1)
- MGMT (1)
- MLL (1)
- MRI (1)
- MTOR inhibitor (1)
- Marginal integrity (1)
- Mesenchymal stem cells (1)
- Metabolomics (1)
- Microgap (1)
- Mobil-Stationen (1)
- Mutation databases (1)
- Noninferiority (1)
- Obesity (1)
- Panel testing (1)
- Patient portals (1)
- Patientenportale (1)
- Pedelecs (1)
- Peg3 (1)
- Plasma (1)
- Proteinkinase (1)
- Rare diseases (1)
- Renal lesions (1)
- SLC20A1 (1)
- Sampling protocol (1)
- Seizure (1)
- Seltene Erkrankungen (1)
- Serum (1)
- Sociodemographic characteristics (1)
- Subependymal giant cell astrocytoma (1)
- TAVR (1)
- TSC (1)
- Temozolomide (1)
- Transcriptome analysis (1)
- Umweltbilanz (1)
- VASP (1)
- Versorgungszentren (1)
- acute leukemia (1)
- acute myeloid leukemia (1)
- air pressure (1)
- angiostasis (1)
- aortic stenosis (1)
- autophagy (1)
- bacterial leakage (1)
- bioacoustics (1)
- bioactivity testing (1)
- bladder exstrophy-epispadias complex (1)
- cAMP (1)
- cGMP (1)
- cell therapy (1)
- chromosomal translocations (1)
- cloacal malformation (1)
- conical coupling (1)
- conometric connection (1)
- cytarabine dose (1)
- easyPACId (1)
- elderly (1)
- functional genetics (1)
- graft-versus host (1)
- hospital exemption (1)
- humidity (1)
- kidney formation (1)
- marginal fit (1)
- mesenchymal stromal cell (1)
- mitophagy (1)
- mitostatin (1)
- natural products (1)
- noise (1)
- proteobacteria (1)
- proteoglycans (1)
- refractory aGvHD (1)
- simplified production (1)
- soil temperature (1)
- steroid-resistant aGvHD (1)
- temperature (1)
- transcatheter aortic valve replacement (1)
- transfemoral (1)
- translocation partner genes (1)
- transplantation (1)
- urbanity gradient (1)
- urbanization (1)
- urinary tract development (1)
- zebrafish development (1)
Institute
- Medizin (24)
- Physik (9)
- Institut für Ökologie, Evolution und Diversität (2)
- Neuere Philologien (2)
- Sonderforschungsbereiche / Forschungskollegs (2)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (2)
- Biowissenschaften (1)
- Center for Financial Studies (CFS) (1)
- Geographie (1)
- House of Finance (HoF) (1)
Introduction: Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) occurs approximately 1 in 3.500 live births representing the most common malformation of the upper digestive tract. Only half a century ago, EA/TEF was fatal among affected newborns suggesting that the steady birth prevalence might in parts be due to mutational de novo events in genes involved in foregut development.
Methods: To identify mutational de novo events in EA/TEF patients, we surveyed the exome of 30 case-parent trios. Identified and confirmed de novo variants were prioritized using in silico prediction tools. To investigate the embryonic role of genes harboring prioritized de novo variants we performed targeted analysis of mouse transcriptome data of esophageal tissue obtained at the embryonic day (E) E8.5, E12.5, and postnatal.
Results: In total we prioritized 14 novel de novo variants in 14 different genes (APOL2, EEF1D, CHD7, FANCB, GGT6, KIAA0556, NFX1, NPR2, PIGC, SLC5A2, TANC2, TRPS1, UBA3, and ZFHX3) and eight rare de novo variants in eight additional genes (CELSR1, CLP1, GPR133, HPS3, MTA3, PLEC, STAB1, and PPIP5K2). Through personal communication during the project, we identified an additional EA/TEF case-parent trio with a rare de novo variant in ZFHX3. In silico prediction analysis of the identified variants and comparative analysis of mouse transcriptome data of esophageal tissue obtained at E8.5, E12.5, and postnatal prioritized CHD7, TRPS1, and ZFHX3 as EA/TEF candidate genes. Re-sequencing of ZFHX3 in additional 192 EA/TEF patients did not identify further putative EA/TEF-associated variants.
Conclusion: Our study suggests that rare mutational de novo events in genes involved in foregut development contribute to the development of EA/TEF.